A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS

• Status: Completed
• Trial end date: 2018-08-05
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized pilot study to characterize engraftment of a donor's microflora onto patients with Irritable Bowel Syndrome with diarrhea following fecal microbiota transplantation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beth Israel Deaconess Medical Center
• Collaborator: OpenBiome
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular

Criteria

Inclusion Criteria:

• IBS with diarrhea